/

Empresas

Av

No verificado

Avanzanite Bioscience B.V.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

14 Comunicados de prensa

Ver todos los comunicados de prensa

18/11/2025

Avanzanite Bioscience Secures €32M Series A Investment from MVM Partners

Fuente

Avanzanite Bioscience B.V.

Editor

1.00

0

17/10/2025

Ciencia

Biotecnología

Farmacéutica

Salud

Medicina - Varios

Sanidad

Industria

Agios, partner di Avanzanite Bioscience, annuncia un parere positivo del CHMP per l’utilizzo di mitapivat in adulti con talassemia

Fuente

Avanzanite Bioscience B.V.

Editor

1.00

0

17/10/2025

Ciencia

Biotecnología

Farmacéutica

Salud

Medicina - Varios

Sanidad

Industria

Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia

Fuente

Avanzanite Bioscience B.V.

Editor

1.00

0

14/10/2025

Giovanni Galliano è il nuovo General Manager Italia di Avanzanite

Fuente

Avanzanite Bioscience B.V.

Editor

1.00

0

14/10/2025

Avanzanite Expands Italian Operations with General Manager Appointment

Fuente

Avanzanite Bioscience B.V.

Editor

1.00

0

10/09/2025

Avanzanite Bioscience Welcomes Dr. Mark Bechter as SVP Medical Affairs

Fuente

Avanzanite Bioscience B.V.

Editor

1.00

0

11/06/2025

Avanzanite annuncia la partnership paneuropea con Agios per lanciare mitapivat nelle malattie ematologiche rare

Fuente

Avanzanite Bioscience B.V.

Editor

1.00

0

09/06/2025

Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders

Fuente

Avanzanite Bioscience B.V.

Editor

1.00

0

10/04/2025

Avanzanite Bioscience Appoints Sotiris Botozis as General Manager Southern Europe

Fuente

Avanzanite Bioscience B.V.

Editor

1.00

0

03/02/2025

Avanzanite Bioscience Appoints Chief Financial Officer

Fuente

Avanzanite Bioscience B.V.

Editor

1.00

0

Seguidores

0

Compatibilidad

0